Tech
Despite Drug Industry Claims, Higher List Prices Do Mean Higher Out-of-Pocket Costs for Many Patients
New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs—at least for some patients. This is counter to a common industry claim that patients aren’t affected by list price increases. The study found a link between list prices rising and out-of-pocket…
